Mirae Asset Global Etfs Holdings Ltd. Adaptive Biotechnologies Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 81,903 shares of ADPT stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,903
Previous 68,830
18.99%
Holding current value
$1.18 Million
Previous $511,000
86.69%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ADPT
# of Institutions
262Shares Held
149MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$431 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$168 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$162 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$90 Million1.68% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.3MShares$61.8 Million0.03% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.05B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...